Tentative approval from the FDA lets generic drug makers prepare for market entry while waiting for patents to expire. Learn how patent litigation, strict timelines, and paperwork errors can delay or derail generic drug launches.
Feb 2 2026
© 2026. All rights reserved.
Menu